Raising capital as a start-up can be daunting—from creating pitches to understanding which investors might best suit your company’s mission. The process of raising commercial funding for early-stage life sciences and biotech businesses is very different from obtaining research funding, and it can be challenging for founders to decide which investors to target, where to source them and how to approach them.

There are key differences between UK/U.S. investors, and angel and venture capital funding when it comes to the dynamics of the investors and the terms on which they will invest.

Join us for a roundtable discussion where we will examine some of the key considerations of VC or angel funding. Our special guest founders and funders will help you understand what each has to offer and how they assess businesses for early-stage funding.